Morepen Laboratories Ltd MOREPENLAB-IN:National Stock Exchange of India

*Data is delayed | INR
Last | 1:14 PM IST
34.55quote price arrow down-0.40 (-1.14%)
Volume
780,544
52 week range
32.30 - 62.30
Loading...
  • Open35.15
  • Day High35.25
  • Day Low34.40
  • Prev Close34.95
  • 52 Week High62.30
  • 52 Week High Date09/20/21
  • 52 Week Low32.30
  • 52 Week Low Date06/20/22

Key Stats

  • Market Cap208.24M
  • Shares Out477.79M
  • 10 Day Average Volume1.19M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-38.96

KEY STATS

  • Open35.15
  • Day High35.25
  • Day Low34.40
  • Prev Close34.95
  • 52 Week High62.30
  • 52 Week High Date09/20/21
  • 52 Week Low32.30
  • 52 Week Low Date06/20/22
  • Market Cap208.24M
  • Shares Out477.79M
  • 10 Day Average Volume1.19M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-38.96

RATIOS/PROFITABILITY

  • EPS (TTM)1.70
  • P/E (TTM)20.32
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date09/18/2002
  • Div Amount0.60
  • Split Date-
  • Split Factor-

Latest On Morepen Laboratories Ltd

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Morepen Laboratories Limited is an India-based pharmaceutical company. The Company is in the business of manufacturing, producing, developing and marketing a range of active pharmaceutical ingredients (APIs), branded and generic formulations and also the home health products. Its APIs include Apixaban, Edoxaban, Sitagliptin, Linagliptin, Empagliflozin, Atorvastatin, Loratadine, Desloratadine, Montelukast Sodium, Atorvastatin Calcium, Fexofenadine, Sitagliptin Phosphate...
Sushil Suri
Executive Chairman of the Board, Managing Director
Address
Village Malkumajra, Nalagarh Road,Baddi
New Delhi
110001
India